Platelet PECAM-1 inhibits thrombus formation in vivo
- 15 January 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 107 (2) , 535-541
- https://doi.org/10.1182/blood-2005-04-1512
Abstract
Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a cell surface glycoprotein receptor expressed on a range of blood cells, including platelets, and on vascular endothelial cells. PECAM-1 possesses adhesive and signaling properties, the latter being mediated by immunoreceptor tyrosine-based inhibitory motifs present on the cytoplasmic tail of the protein. Recent studies in vitro have demonstrated that PECAM-1 signaling inhibits the aggregation of platelets. In the present study we have used PECAM-1–deficient mice and radiation chimeras to investigate the function of this receptor in the regulation of thrombus formation. Using intravital microscopy and laser-induced injury to cremaster muscle arterioles, we show that thrombi formed in PECAM-1–deficient mice were larger, formed more rapidly than in control mice, and were more stable. Larger thrombi were also formed in control mice that received transplants of PECAM-1–deficient bone marrow, in comparison to mice that received control transplants. A ferric chloride model of thrombosis was used to investigate thrombus formation in carotid arteries. In PECAM-1–deficient mice the time to 75% vessel occlusion was significantly shorter than in control mice. These data provide evidence for the involvement of platelet PECAM-1 in the negative regulation of thrombus formation.Keywords
This publication has 72 references indexed in Scilit:
- Endothelial cell PECAM-1 confers protection against endotoxic shockAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- PECAM-1 negatively regulates GPIb/V/IX signaling in murine plateletsBlood, 2003
- Physical proximity and functional interplay of PECAM-1 with the Fc receptor FcγRIIa on the platelet plasma membraneBlood, 2003
- Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)–mediated activation, and autoimmune diseaseBlood, 2002
- Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibα is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathwayBiochemical Journal, 2002
- PECAM-1 (CD31) Expression Modulates Bleeding Time in VivoThe American Journal of Pathology, 2000
- Engagement of human PECAM-1 (CD31) on human endothelial cells increases intracellular calcium ion concentration and stimulates prostacyclin release.Journal of Clinical Investigation, 1998
- Individually Distinct Ig Homology Domains in PECAM-1 Regulate Homophilic Binding and Modulate Receptor AffinityJournal of Biological Chemistry, 1996
- Role of Platelet-Endothelial Cell Adhesion Molecule (PECAM) in Platelet Adhesion/Aggregation Over Injured but Not Denuded Endothelium In Vivo and Ex VivoStroke, 1996
- Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule.The Journal of cell biology, 1991